Chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meeting the diagnostic criteria for chronic obstructive pulmonary disease (COPD) in Western medicine. 2. Stable condition for the past four weeks with no acute exacerbations. 3. Diagnosed with lung-kidney deficiency and phlegm-blood stasis obstructing the lung syndrome based on Traditional Chinese Medicine (TCM) differentiation. 4. Aged 40–80 years with no gender restrictions. 5. Willing to comply with the physicians diagnosis and treatment plan and providing signed informed consent. Only patients meeting all the above criteria will be included in the study.
Exclusion criteria
Exclusion criteria: 1. Presence of severe primary diseases of the cardiovascular cerebrovascular hepatic renal gastrointestinal hematologic or endocrine systems. 2. Women who are pregnant breastfeeding or planning pregnancy within six months. 3. Abnormal liver or kidney function: serum creatinine (Scr) > 1.5 times the upper normal limit and/or aspartate aminotransferase (AST) or alanine aminotransferase (ALT) > 2 times the upper normal limit. 4. History of allergies or known hypersensitivity to the study medication. 5. History of psychiatric disorders intellectual disability mobility impairment or any condition that may affect informed consent validity. 6. Participation in other clinical trials within the past three months. 7. Other conditions deemed unsuitable for inclusion by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COPD Assessment Test (CAT) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary function test (PFT);Number of acute exacerbations;modified British medical research council; | — |
Contacts
Xiyuan Hospital China Academy of Chinese Medical Sciences